Delivery Order SPE2DB20D3103-SPE2DB22FL5V8
Award Date 11/5/21
Potential Completion Date 11/30/21
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,677.16 firm-fixed-price delivery order covers the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a performance period ending August 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $9,391.75 Delivery Order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,391.75 firm fixed price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $1,878.35 firm-fixed price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of a specialty pharmaceutical product, HYPERRAB 300 UNIT/ML VIALML, with a potential value of $4,466.28 and a completion date of February 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This federal contract award, with ID SPE2DX15D6028|SPE2DX24FWMPC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,560.14 firm fixed-price delivery order is for the supply of HYPERRAB 300UNIT/ML 1S medical products, with a completion date of May 3, 2024. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is the prime contractor for this award. The contract does not have a set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,721.90 firm fixed price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL, a specialty pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to...
- The federal contract award summarized is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $10,686.55 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 7, 2025, with a completion date of March 28, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract worth $3,373.68 by the Defense Logistics Agency (DLA) to provide HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceuticals. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. The company also holds an Indefinite Delivery Contract with DLA worth up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $7,513.40 award is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...